Diabetes Clinical Trials in San Francisco

Showing 61-80 of 255 trials

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk

NCT05166525

This study is a virtual, remote, decentralized pragmatic clinical trial comparing the efficacy of medically tailored meals alone or medically tailored meals with remote nutritional counseling compared with usual standard of care in adults with a targeted, nutrition-sensitive chronic medical condition (heart failure, diabetes mellitus, chronic kidney disease).

Heart FailureChronic Kidney DiseasesDiabetes Mellitus, Type 2

Kaiser Permanente2,000 participantsStarted Apr 2020

Oakland, California, United States • San Francisco, California, United States • San Rafael, California, United States +2 more locations

COMPLETEDPHASE1< 1 mile

T1DM Immunotherapy Using Polyclonal Tregs + IL-2

NCT02772679

The purpose of this study is to assess the safety of Tregs + IL-2 and survival of Tregs in patients with recent onset T1DM who receive infusions of autologous Tregs + IL-2.

Type 1 Diabetes Mellitus

Jeffrey Bluestone16 participantsStarted Aug 2016

San Francisco, California, United States • New Haven, Connecticut, United States

COMPLETEDPHASE313 miles

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

NCT01499082

Primary Objective: * To compare the efficacy of insulin glargine new formulation and Lantus in terms of change in HbA1c from baseline to endpoint (scheduled month 6) in adult participants with type 2 diabetes mellitus Secondary Objectives: * To compare the efficacy of insulin glargine new formulation and Lantus in terms of occurrence of nocturnal Hypoglycemia

Type 2 Diabetes Mellitus

Sanofi807 participantsStarted Dec 2011

Chandler, Arizona, United States • Glendale, Arizona, United States • Phoenix, Arizona, United States +190 more locations

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk

T1DM Immunotherapy Using Polyclonal Tregs + IL-2

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

Diabetes Trials in Other Cities

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

Adverse Metabolic Effects of Dietary Sugar

The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men

Onduo Virtual Diabetes Clinic Study

Evaluation of Extended Wear Infusion Set With 670G Hybrid Closed-Loop Therapy

Overcoming Barriers and Obstacles to Adopting Diabetes Devices

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus

Alveolar Bone Changes in Diabetes (ABCD) Study

Other Conditions in San Francisco